Literature DB >> 266540

The response to inactivated influenza A (H3N2) vaccines: the development and effect of antibodies to the surface antigens.

A F Smith, J R Davies.   

Abstract

A controlled trial of influenza vaccines in a boys' public school from November 1970 to October 1975 provided an opportunity to study the response to vaccine and the effect on subsequent natural challenge in boys with differing natural experience of influenza A strains. The response to influenza A (H3N2) vaccines was assessed by estimating homotypic and heterotypic antibodies to the surface antigens. Previous natural experience of influenza A was found to influence vaccine response and the effect of natural challenge. The antibody response to revaccination with the same strain showed a progressively poorer response to second and third doses. The protectitive effect of naturally acquired and vaccine-induced antibodies was assessed during two outbreaks of influenza A which occurred in the trial period.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 266540      PMCID: PMC2129882          DOI: 10.1017/s0022172400056266

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  16 in total

1.  Response to influenza vaccine in adjuvant 65-4.

Authors:  J W Smith; W B Fletcher; M Peters; M Westwood; F J Perkins
Journal:  J Hyg (Lond)       Date:  1975-04

2.  A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group.

Authors:  C W Potter; R Jennings; C McLaren; D Edey; C H Stuart-Harris; M Brady
Journal:  J Hyg (Lond)       Date:  1975-12

3.  Vaccination in the control of influenza.

Authors:  J W Smith; W B Fletcher; P J Wherry
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

4.  Efficacy of "Hong Kong" vaccine in preventing "England" variant influenza A in 1972.

Authors:  H G Stiver; P Graves; T C Eickhoff; G Meiklejohn
Journal:  N Engl J Med       Date:  1973-12-13       Impact factor: 91.245

5.  Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain.

Authors:  T W Hoskins; J R Davies; A Allchin; C L Miller; T M Pollock
Journal:  Lancet       Date:  1973-07-21       Impact factor: 79.321

6.  Placebo-controlled double-blind clinical studies on the efficacy of different influenza vaccines assessed by experimental and natural infection.

Authors:  F E André; P Uytterschaut; I T Niculescu; G Virlan; E Zilisteanu; S Smerdel; I Vodopija
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

7.  Assessment of vaccine efficacy by challenge studies in man.

Authors:  D A Tyrrell
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

8.  Influenza at Christ's Hospital: March, 1974.

Authors:  T W Hoskins; J R Davies; A J Smith; A Allchin; C L Miller; T M Pollock
Journal:  Lancet       Date:  1976-01-17       Impact factor: 79.321

9.  Natural infection with influenza A (H3N2). The development, persistance and effect of antibodies to the surface antigens.

Authors:  A J Smith; J R Davies
Journal:  J Hyg (Lond)       Date:  1976-10

10.  Comparative trials of live attenuated and detergent split influenza virus vaccines.

Authors:  J S Mackenzie; I Mackenzie; J Lloyd; V Dent
Journal:  J Hyg (Lond)       Date:  1975-12
View more
  4 in total

1.  Influenza 1980-1.

Authors: 
Journal:  Br Med J       Date:  1980-08-23

2.  Sequential infection or immunization of ferrets with a series of influenza A (H3N2) strains (report to the Medical Research Council's Sub-Committee on influenza Vaccines (CDVIP/IV)).

Authors:  C W Potter; R Jennings; M J Ali; J M Wood; U Dunleavy; D A Tyrrell
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

3.  Morphology and antigenicity studies on reassortant influenza (H3N2) viruses for use in inactivated vaccines.

Authors:  R M Pemberton; R Jennings; T L Smith
Journal:  J Hyg (Lond)       Date:  1985-04

Review 4.  Vaccines for preventing influenza in healthy adults.

Authors:  Vittorio Demicheli; Tom Jefferson; Eliana Ferroni; Alessandro Rivetti; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.